Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PV-10 vs Chemotherapy or T-VEC in Locally Advanced Cutaneous Melanoma
NCT02288897Phase 3Terminated
- Sponsor
- Provectus Biopharmaceuticals
- Start
- Apr 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of PV-10 in cutaneous melanoma (CM), sponsored by Provectus Biopharmaceuticals. Started Apr 2015; status: terminated.
02
Drugs
PV-10
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT02288897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02288897.